Association between the use of loop diuretics and prognosis in critically ill patients with acute kidney injury: a retrospective propensity score-matched cohort study.
{"title":"Association between the use of loop diuretics and prognosis in critically ill patients with acute kidney injury: a retrospective propensity score-matched cohort study.","authors":"Hua Xiao, Kai Liu, Hong-Hao Meng, Yun-Peng Peng, Guo-Bao Hong, Xin-Zhou Zhang","doi":"10.1007/s11255-024-04271-7","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The role of loop diuretics in patients with acute kidney injury (AKI) is controversial. This study examined the association between the use of loop diuretics and prognosis in critically ill patients with AKI.</p><p><strong>Methods: </strong>This study used data from the medical information mart for the intensive care IV database. Adult critically ill patients with AKI were included in the analysis. Patients were partitioned into two groups based on their use of loop diuretics in the ICU, and potentially confounding variables between the two groups were balanced using propensity score matching (PSM). We used time-dependent Cox proportional hazards regression, logistic regression, and Hodges-Lehman estimator to assess the impact of loop diuretics on all-cause mortality, renal replacement therapy (RRT) use, and the length of hospital stay, respectively.</p><p><strong>Results: </strong>This study included a cohort of 19,671 patients. After PSM, both groups consisted of 6200 patients. The use of loop diuretics was associated with a lower risk of in-hospital mortality (HR, 0.672; 95% CI 0.597-0.757; P < 0.001), lower in-ICU mortality (HR, 0.375; 95% CI 0.315-0.446; P < 0.001), and lower odds of in-hospital RRT (OR, 0.472; 95% CI 0.400-0.555; P < 0.001). A sensitivity analysis using the original cohort (HR, 0.624; 95% CI 0.561-0.693; P < 0.001) and weighted cohort (HR, 0.654; 95% CI 0.582-0.736; P < 0.001) also demonstrated lower in-hospital all-cause mortality.</p><p><strong>Conclusions: </strong>The use of loop diuretics is associated with a substantial reduction in mortality among critically ill patients with AKI.</p>","PeriodicalId":14454,"journal":{"name":"International Urology and Nephrology","volume":" ","pages":""},"PeriodicalIF":1.8000,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Urology and Nephrology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11255-024-04271-7","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: The role of loop diuretics in patients with acute kidney injury (AKI) is controversial. This study examined the association between the use of loop diuretics and prognosis in critically ill patients with AKI.
Methods: This study used data from the medical information mart for the intensive care IV database. Adult critically ill patients with AKI were included in the analysis. Patients were partitioned into two groups based on their use of loop diuretics in the ICU, and potentially confounding variables between the two groups were balanced using propensity score matching (PSM). We used time-dependent Cox proportional hazards regression, logistic regression, and Hodges-Lehman estimator to assess the impact of loop diuretics on all-cause mortality, renal replacement therapy (RRT) use, and the length of hospital stay, respectively.
Results: This study included a cohort of 19,671 patients. After PSM, both groups consisted of 6200 patients. The use of loop diuretics was associated with a lower risk of in-hospital mortality (HR, 0.672; 95% CI 0.597-0.757; P < 0.001), lower in-ICU mortality (HR, 0.375; 95% CI 0.315-0.446; P < 0.001), and lower odds of in-hospital RRT (OR, 0.472; 95% CI 0.400-0.555; P < 0.001). A sensitivity analysis using the original cohort (HR, 0.624; 95% CI 0.561-0.693; P < 0.001) and weighted cohort (HR, 0.654; 95% CI 0.582-0.736; P < 0.001) also demonstrated lower in-hospital all-cause mortality.
Conclusions: The use of loop diuretics is associated with a substantial reduction in mortality among critically ill patients with AKI.
背景:襻利尿剂在急性肾损伤(AKI)患者中的作用存在争议。本研究探讨了襻利尿剂的使用与 AKI 重症患者预后之间的关系:本研究使用的数据来自重症监护 IV 数据库的医疗信息集市。分析对象包括患有 AKI 的成人重症患者。根据患者在重症监护室使用襻利尿剂的情况将其分为两组,并使用倾向得分匹配法(PSM)平衡两组之间可能存在的混杂变量。我们使用时间依赖性 Cox 比例危险回归、逻辑回归和霍奇斯-雷曼估计器分别评估了襻利尿剂对全因死亡率、肾脏替代疗法(RRT)使用和住院时间的影响:这项研究包括 19671 名患者。PSM 后,两组患者均为 6200 人。使用襻利尿剂与较低的院内死亡风险相关(HR,0.672;95% CI 0.597-0.757;P 结论:使用襻利尿剂与较低的院内死亡风险相关(HR,0.672;95% CI 0.597-0.757;P):使用襻利尿剂可大幅降低AKI重症患者的死亡率。
期刊介绍:
International Urology and Nephrology publishes original papers on a broad range of topics in urology, nephrology and andrology. The journal integrates papers originating from clinical practice.